$415 Million is the total value of Sio Capital Management, LLC's 71 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LXRX | Exit | LEXICON PHARMACEUTICALS INCput | $0 | – | -21,600 | -100.0% | -0.03% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -3,000 | -100.0% | -0.06% | – |
| MASI | Exit | MASIMO CORPput | $0 | – | -3,300 | -100.0% | -0.12% | – |
| RMED | Exit | RA MEDICAL SYSTEMS INC | $0 | – | -173,652 | -100.0% | -0.16% | – |
| OSMT | Exit | OSMOTICA PHARMACEUTICALS PLC | $0 | – | -346,410 | -100.0% | -0.34% | – |
| IDXG | Exit | INTERPACE DIAGNOSTICS GROUP INC | $0 | – | -1,653,097 | -100.0% | -0.36% | – |
| GNFT | Exit | GENFIT SAads | $0 | – | -92,637 | -100.0% | -0.60% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INCput | $0 | – | -21,800 | -100.0% | -0.66% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -239,827 | -100.0% | -0.86% | – |
| PEN | Exit | PENUMBRA INCput | $0 | – | -24,000 | -100.0% | -0.95% | – |
| SYK | Exit | STRYKER CORPput | $0 | – | -19,200 | -100.0% | -1.02% | – |
| VAR | Exit | VARIAN MEDICAL SYSTEMS INCput | $0 | – | -27,600 | -100.0% | -1.06% | – |
| PETS | Exit | PETMED EXPRESS INC | $0 | – | -178,151 | -100.0% | -1.10% | – |
| SRCL | Exit | STERICYCLE INC | $0 | – | -75,000 | -100.0% | -1.10% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -1,609,265 | -100.0% | -1.12% | – |
| EGRX | Exit | EAGLE PHARMACEUTICALS INC | $0 | – | -84,695 | -100.0% | -1.15% | – |
| ISRG | Exit | INTUITIVE SURGICAL INCput | $0 | – | -9,900 | -100.0% | -1.52% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -51,300 | -100.0% | -1.62% | – |
| SNY | Exit | SANOFI SAsponsored adr | $0 | – | -156,854 | -100.0% | -1.88% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -530,175 | -100.0% | -1.99% | – |
| NVO | Exit | NOVO NORDISK A/Sadr | $0 | – | -162,000 | -100.0% | -2.29% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCput | $0 | – | -50,800 | -100.0% | -2.31% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INCput | $0 | – | -165,500 | -100.0% | -2.83% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -90,325 | -100.0% | -2.87% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -245,968 | -100.0% | -4.32% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -78,596 | -100.0% | -5.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS ORD | 24 | Q4 2023 | 8.3% |
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 19 | Q1 2024 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| THE CIGNA GROUP | 17 | Q2 2024 | 11.0% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 14, 2024 | 280,000 | 7.5% |
| Gracell Biotechnologies Inc. | February 14, 2024 | 25,007,900 | 5.2% |
| Modular Medical, Inc. | February 14, 2024 | 2,110,260 | 10.0% |
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-26 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.